Serum endostatin levels are elevated in colorectal cancer and correlate with invasion and systemic inflammatory markers

British Journal of Cancer

Volumn 111, Issue 8, 2014, Pages 1605-1613

  Kantola, T ^a,b,c   Vayrynen J P ^a,b,c   Klintrup, K ^a,b,c   Makela J ^a,b,c   Karppinen, S M ^a   Pihlajaniemi, T ^a   Autio Harmainen, H ^a,b,c   Karttunen, T J ^a,b,c   Makinen M J ^a,b,c   Tuomisto, A ^a,b,c  

^a UNIVERSITY OF OULU   (Finland)

^b OULU UNIVERSITY HOSPITAL   (Finland)

^c MEDICAL RESEARCH CENTER OULU   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 18; ENDOSTATIN; TUMOR MARKER;

AGED; BLOOD; COLORECTAL TUMOR; COMPLICATION; FEMALE; HUMAN; INFLAMMATION; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; TUMOR INVASION;

AGED; COLLAGEN TYPE XVIII; COLORECTAL NEOPLASMS; ENDOSTATINS; FEMALE; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; TUMOR MARKERS, BIOLOGICAL;

EID: 84908879253     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2014.456     Document Type: Article

References (59)

1. Abdollahi A, Hahnfeldt P, Maercker C, Gröne H-J, Debus J, Ansorge W, Folkman J, Hlatky L, Huber PE (2004) Endostatin's antiangiogenic signaling network. Mol Cell 13: 649-663.
2. Bi Z, Dong L-D, Gu X-M (2013) Clinical significance of MMP-7 and PTEN expression in colorectal cancer. Hepatogastroenterology 60: 32-36.
3. Brabletz T, Jung A, Dag S, Hlubek F, Kirchner T (1999) beta-catenin regulates the expression of the matrix metalloproteinase-7 in human colorectal cancer. Am J Pathol 155: 1033-1038.
4. Brideau G, Mäkinen MJ, Elamaa H, Tu H, Nilsson G, Alitalo K, Pihlajaniemi T, Heljasvaara R (2007) Endostatin overexpression inhibits lymphangiogenesis and lymph node metastasis in mice. Cancer Res 67: 11528-11535.
5. Carlsson AC, Ruge T, Sundström J, Ingelsson E, Larsson A, Lind L, Arnlöv J (2013) Association between circulating endostatin, hypertension duration, and hypertensive target-organ damage. Hypertension 62: 1146-1151.
6. Celik I, Sürücü O, Dietz C, Heymach JV, Force J, Höschele I, Becker CM, Folkman J, Kisker O (2005) Therapeutic efficacy of endostatin exhibits a biphasic dose-response curve. Cancer Res 65: 11044-11050.
7. Columbo M, Bochner BS (2001) Human skin mast cells adhere to vitronectin via the alphavbeta3 integrin receptor (CD51/CD61). J Allergy Clin Immunol 107: 554.
8. Columbo M, Bochner BS, Marone G (1995) Human skin mast cells express functional beta 1 integrins that mediate adhesion to extracellular matrix proteins. J Immunol 154: 6058-6064.
9. Delaney CE, Weagant BT, Addison CL (2006) The inhibitory effects of endostatin on endothelial cells are modulated by extracellular matrix. Exp Cell Res 312: 2476-2489.
10. Dhanabal M, Ramchandran R, Waterman MJ, Lu H, Knebelmann B, Segal M, Sukhatme VP (1999) Endostatin induces endothelial cell apoptosis. J Biol Chem 274: 11721-11726.
11. Fainaru O, Almog N, Yung CW, Nakai K, Montoya-Zavala M, Abdollahi A, D'Amato R, Ingber DE (2010) Tumor growth and angiogenesis are dependent on the presence of immature dendritic cells. FASEB J 24: 1411-1418.
12. Faye C, Moreau C, Chautard E, Jetne R, Fukai N, Ruggiero F, Humphries MJ, Olsen BR, Ricard-Blum S (2009) Molecular interplay between endostatin, integrins, and heparan sulfate. J Biol Chem 284: 22029-22040.
13. Feldman AL, Pak H, Yang JC, Alexander HR, Libutti SK (2001) Serum endostatin levels are elevated in patients with soft tissue sarcoma. Cancer 91: 1525-1529.
14. Folkman J (2006) Antiangiogenesis in cancer therapy-endostatin and its mechanisms of action. Exp Cell Res 312: 594-607.
15. Folkman J, Klagsbrun M (1987) Angiogenic factors. Science 235: 442-447.
16. Folkman J, Long DM, Becker FF (1963) Growth and metastasis of tumor in organ culture. Cancer 16: 453-467.
17. González LO, Pidal I, Junquera S, Corte MD, Vázquez J, Rodróguez JC, Lamelas ML, Merino AM, Garc?á-Muniz JL, Vizoso FJ (2007) Overexpression of matrix metalloproteinases and their inhibitors in mononuclear inflammatory cells in breast cancer correlates with metastasis-relapse. Br J Cancer 97: 957-963.
18. Heljasvaara R, Nyberg P, Luostarinen J, Parikka M, Heikkilä P, Rehn M, Sorsa T, Salo T, Pihlajaniemi T (2005) Generation of biologically active endostatin fragments from human collagen XVIII by distinct matrix metalloproteases. Exp Cell Res 307: 292-304.
19. Huang AY, Golumbek P, Ahmadzadeh M, Jaffee E, Pardoll D, Levitsky H (1994) Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens. Science 264: 961-965.
20. Jain RK (2005) Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy. Science 307: 58-62.
21. Jancic C, Chuluyan HE, Morelli A, Larregina A, Kolkowski E, Saracco M, Barboza M, Leiva WS, Fainboim L (1998) Interactions of dendritic cells with fibronectin and endothelial cells. Immunology 95: 283-290.
22. Kantola T, Klintrup K, Väyrynen JP, Vornanen J, Bloigu R, Karhu T,Herzig K-H, Näpänkangas J, Mäkelä J, Karttunen TJ, Tuomisto A, Mäkinen MJ (2012) Stage-dependent alterations of the serum cytokine pattern in colorectal carcinoma. Br J Cancer 107: 1729-1736.
23. Karumanchi SA, Jha V, Ramchandran R, Karihaloo A, Tsiokas L, Chan B, Dhanabal M, Hanai JI, Venkataraman G, Shriver Z, Keiser N, Kalluri R, Zeng H, Mukhopadhyay D, Chen RL, Lander AD, Hagihara K, Yamaguchi Y, Sasisekharan R, Cantley L, Sukhatme VP (2001) Cell surface glypicans are low-affinity endostatin receptors. Mol Cell 7: 811-822.
24. Kim Y-M, Hwang S, Kim Y-M, Pyun B-J, Kim T-Y, Lee S-T, Gho YS, Kwon Y-G (2002) Endostatin blocks vascular endothelial growth factor-mediated signaling via direct interaction with KDR/Flk-1. J Biol Chem 277: 27872-27879.
25. Kim YM, Jang JW, Lee OH, Yeon J, Choi EY, Kim KW, Lee ST, Kwon YG (2000) Endostatin inhibits endothelial and tumor cellular invasion by blocking the activation and catalytic activity of matrix metalloproteinase. Cancer Res 60: 5410-5413.
26. Kojima T, Azar DT, Chang J-H (2008) Neostatin-7 regulates bFGF-induced corneal lymphangiogenesis. FEBS Lett 582: 2515-2520.
27. Li C, Harris MB, Venema VJ, Venema RC (2005) Endostatin induces acute endothelial nitric oxide and prostacyclin release. Biochem Biophys Res Commun 329: 873-878.
28. Li M, Liu F, Sun P, Gao Y, Chen H, Liu H, Wang M, Chen J, Zhao Y (2012) Correlations between serum levels of vascular endothelial growth factor and endostatin with clinical pathological characteristics of patients with gastrointestinal cancers. Hepatogastroenterology 59: 1865-1868.
29. Maltby S, Khazaie K, McNagny KM (2009) Mast cells in tumor growth: angiogenesis, tissue remodelling and immune-modulation. Biochim Biophys Acta 1796: 19-26.
30. Mantovani A, Allavena P, Sica A, Balkwill F (2008) Cancer-related inflammation. Nature 454: 436-444.
31. McMillan DC (2013) The systemic inflammation-based Glasgow Prognostic Score: a decade of experience in patients with cancer. Cancer Treat Rev 39: 534-540.
32. Mitsuma W, Kodama M, Hanawa H, Ito M, Ramadan MM, Hirono S, Obata H, Okada S, Sanada F, Yanagawa T, Kashimura T, Fuse K, Tanabe N, Aizawa Y (2007) Serum endostatin in the coronary circulation of patients with coronary heart disease and its relation to coronary collateral formation. Am J Cardiol 99: 494-498.
33. Nagtegaal ID, Marijnen CA, Kranenbarg EK, Mulder-Stapel A, Hermans J, van de Velde CJ, van Krieken JH, Committee PR (2002a) Short-term preoperative radiotherapy interferes with the determination of pathological parameters in rectal cancer. J Pathol 197: 20-27.
34. Nagtegaal ID, Marijnen CAM, Kranenbarg EK, Mulder-Stapel A, Hermans J, van de Velde CJH, van Krieken JHJM (2002b) Short-term preoperative radiotherapy interferes with the determination of pathological parameters in rectal cancer. J Pathol 197: 20-27.
35. Nielsen BS, Timshel S, Kjeldsen L, Sehested M, Pyke C, Borregaard N, Danø K (1996) 92 kDa type IV collagenase (MMP-9) is expressed in neutrophils and macrophages but not in malignant epithelial cells in human colon cancer. Int J Cancer 65: 57-62.
36. Nyberg P, Heikkilä P, Sorsa T, Luostarinen J, Heljasvaara R, Stenman U-H, Pihlajaniemi T, Salo T (2003) Endostatin inhibits human tongue carcinoma cell invasion and intravasation and blocks the activation of matrix metalloprotease-2,-9, and-13. J Biol Chem 278: 22404-22411.
37. O'Reilly MS, Boehm T, Shing Y, Fukai N, Vasios G, Lane WS, Flynn E, Birkhead JR, Olsen BR, Folkman J (1997) Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 88: 277-285.
38. Peeters CFJM, de Geus L-F, Westphal JR, deWaal RMW, Ruiter DJ, Wobbes T, Oyen WJG, Ruers TJ (2005) Decrease in circulating anti-angiogenic factors (angiostatin and endostatin) after surgical removal of primary colorectal carcinoma coincides with increased metabolic activity of liver metastases. Surgery 137: 246-249.
39. Rehn M, Veikkola T, Kukk-Valdre E, Nakamura H, Ilmonen M, Lombardo C, Pihlajaniemi T, Alitalo K, Vuori K (2001) Interaction of endostatin with integrins implicated in angiogenesis. Proc Natl Acad Sci USA 98: 1024-1029.
40. Roxburgh CS, McMillan DC (2010) Role of systemic inflammatory response in predicting survival in patients with primary operable cancer. Future Oncol 6: 149-163.
41. Saarela J, Rehn M, Oikarinen A, Autio-Harmainen H, Pihlajaniemi T (1998) The short and long forms of type XVIII collagen show clear tissue specificities in their expression and location in basement membrane zones in humans. Am J Pathol 153: 611-626.
42. Schmidt A, Addicks K, Bloch W (2004) Opposite effects of endostatin on different endothelial cells. Cancer Biol Ther 3: 1162-1166discussion 1167-8.
43. Seemann I, Gabriels K, Visser NL, Hoving S, te Poele JA, Pol JF, Gijbels MJ, Janssen BJ, van Leeuwen FW, Daemen MJ, Heeneman S, Stewart FA (2012) Irradiation induced modest changes in murine cardiac function despite progressive structural damage to the myocardium and microvasculature. Radiother Oncol 103: 143-150.
44. Seppinen L, Pihlajaniemi T (2011) The multiple functions of collagen XVIII in development and disease. Matrix Biol 30: 83-92.
45. Siegel R, Naishadham D, Jemal A (2013) Cancer statistics, 2013. CA Cancer J Clin 63: 11-30.
46. Skoberne M, Beignon AS, Larsson M, Bhardwaj N (2005) Apoptotic cells at the crossroads of tolerance and immunity. Curr Top Microbiol Immunol 289: 259-292.
47. Suzuki M, Iizasa T, Ko E, Baba M, Saitoh Y, Shibuya K, Sekine Y, Yoshida S, Hiroshima K, Fujisawa T (2002) Serum endostatin correlates with progression and prognosis of non-small cell lung cancer. Lung Cancer 35: 29-34.
48. Szarvas T, László V, Vom Dorp F, Reis H, Szendröi A, Romics I, Tilki D, Rübben H, Ergün S (2012) Serum endostatin levels correlate with enhanced extracellular matrix degradation and poor patients' prognosis in bladder cancer. Int J Cancer 130: 2922-2929.
49. Tjin Tham Sjin RM, Naspinski J, Birsner AE, Li C, Chan R, Lo K-M, Gillies S, Zurakowski D, Folkman J, Samulski J, Javaherian K (2006) Endostatin therapy reveals a U-shaped curve for antitumor activity. Cancer Gene Ther 13: 619-627.
50. Vlems F, van der Worp E, van der Laak J, van de Velde C, Nagtegaal I, van Krieken H (2004) A study into methodology and application of quantification of tumour vasculature in rectal cancer. Virchows Arch 445: 263-270.
51. Väyrynen JP, Tuomisto A, Klintrup K, Mäkelä J, Karttunen TJ, Mäkinen MJ (2013) Detailed analysis of inflammatory cell infiltration in colorectal cancer. Br J Cancer 109: 1839-1847.
52. Väyrynen JP, Vornanen JO, Sajanti S, Böhm JP, Tuomisto A, Mäkinen MJ (2012) An improved image analysis method for cell counting lends credibility to the prognostic significance of T cells in colorectal cancer. Virchows Arch 460: 455-465.
53. Wilson RF, MorseMA, Pei P, Renner RJ, Schuller DE, Robertson FM, Mallery SR (2003) Endostatin inhibits migration and invasion of head and neck squamous cell carcinoma cells. Anticancer Res 23: 1289-1295.
54. Woo IS, Kim K-A, Jeon H-M, Hong SH, Rho SY, Koh SJ, Lee MA, Byun JH, Kang J-H, Hong YS, Lee KS, Cho C-S, Choi MG, Chung I-S (2006) Pretreatment serum endostatin as a prognostic indicator in metastatic gastric carcinoma. Int J Cancer 119: 2901-2906.
55. Wu FPK, Westphal JR, Hoekman K, Mels AK, Statius Muller MG, de Waal RW, Beelen RHJ, van Leeuwen PAM, Meijer S, Cuesta MA (2004) The effects of surgery, with or without rhGM-CSF, on the angiogenic profile of patients treated for colorectal carcinoma. Cytokine 25: 68-72.
56. Yamaguchi N, Anand-Apte B, Lee M, Sasaki T, Fukai N, Shapiro R, Que I, Lowik C, Timpl R, Olsen BR (1999) Endostatin inhibits VEGF-induced endothelial cell migration and tumor growth independently of zinc binding. EMBO J 18: 4414-4423.
57. Yang B, Gao J, Rao Z, Shen Q (2012) Clinicopathological significance and prognostic value of MMP-13 expression in colorectal cancer. Scand J Clin Lab Invest 72: 501-505.
58. Yang B, Gao J, Rao Z, Shen Q (2013) Clinicopathological and prognostic significance of a5b1-integrin and MMP-14 expressions in colorectal cancer. Neoplasma 60: 254-261.
59. Zhang Y, Guan X-Y, Dong B, Zhao M, Wu J-H, Tian X-Y, Hao C-Y (2012) Expression of MMP-9 and WAVE3 in colorectal cancer and its relationship to clinicopathological features. J Cancer Res Clin Oncol 138: 2035-2044.